(lp0
S"Why Kythera Biopharmaceuticals, Inc Rocketed Higher Motley Fool - Mar 5, 2015 What's happening: Shares of Kythera Biopharmaceuticals  soared higher by as much as 20% ahead of a key FDA advisory panel committee meeting next week."
p1
aS'Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion Bloomberg - Jun 17, 2015 Allergan Plc, the maker of wrinkle treatment Botox, agreed to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion to add treatments for double chins and male pattern baldness.Why Kythera Biopharmaceuticals, Inc. Stock Soared Today - Motley FoolAllergan to Acquire KYTHERA Biopharmaceuticals - PR Newswire '
p2
aS'KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors GlobeNewswire  - Jan 5, 2015 WESTLAKE VILLAGE, Calif., Jan. 5, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced that it has named Hollings C. Renton to its Board of Directors.'
p3
aS'KYTHERA Biopharmaceuticals Announces US Availability of KYBELLA -- First ... GlobeNewswire  - Jun 19, 2015 WESTLAKE VILLAGE, Calif., June 19, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced the U.S.'
p4
aS'KYTHERA Acquires Worldwide Rights to Clinical Compound and Key Intellectual ... GlobeNewswire  - Feb 10, 2015 WESTLAKE VILLAGE, Calif., Feb. 10, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced that it has entered into separate license agreements with Actelion Pharmaceuticals Ltd.Kythera Biophrarma  Enters Hair Loss IP Agreement with Actelion Pharma ... - StreetInsider.com'
p5
aS'Allergan to buy Kythera Biopharmaceuticals in $2.1 billion deal MarketWatch - Jun 17, 2015 Allergan PLC AGN, +0.24% announced an deal to buy Kythera Biopharmaceuticals Inc. kyth in a cash and stock deal valued at $2.1 billion.'
p6
aS'KYTHERA Biopharmaceuticals Announces Health Canada Authorization of BELKYRA(TM ... GlobeNewswire  - Jul 27, 2015 WESTLAKE VILLAGE, Calif., July 27, 2015  -- KYTHERA Biopharmaceuticals, Inc.  today announced it has received authorization from Health Canada to market BELKYRA for improvement in the appearance of&nbsp;...Kythera Biophrarma  Receives Marketing Approval for BELKYRA in Canada - StreetInsider.com'
p7
aS"Photo Release -- KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA ... GlobeNewswire  - Apr 29, 2015 WESTLAKE VILLAGE, Calif., April 29, 2015  -- KYTHERA Biopharmaceuticals, Inc.  announced today that the U.S.FDA approves Westlake Village company's drug to reduce double-chin fat - Los Angeles TimesFDA approves treatment for fat below the chin - FDA.gov"
p8
aS'Sell Kythera  Stock, Another Biotech Ripoff Investorplace.com - Mar 9, 2015 Kythera Biopharmaceuticals Inc  stock was halted Monday as an independent advisory committee reviewed its double-chin treatment, ATX-101.FDA Panel Backs Kythera Double-Chin Treatment - Wall Street JournalAn Injection That Makes Double Chins Disappear Is Probably Coming Soon - Yahoo Health'
p9
aS'KYTHERA Biopharmaceuticals Submits New Drug Application for ATX-101 as First ... GlobeNewswire  - May 12, 2014 CALABASAS, Calif., May 12, 2014  -- KYTHERA Biopharmaceuticals, Inc.  today announced it has submitted a New Drug Application  to the U.S.'
p10
a.